Skip to main content
Erschienen in: Abdominal Radiology 5/2012

01.10.2012

Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients

verfasst von: Xiaozhi Zhao, Wei Wang, Shiwei Zhang, Jun Liu, Fan Zhang, Changwei Ji, Xiaogong Li, Weidong Gan, Gutian Zhang, Hongqian Guo

Erschienen in: Abdominal Radiology | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the impact of contrast-enhanced ultrasonography (CEUS) during percutaneous radiofrequency ablation (PRFA) procedure in renal cell carcinoma (RCC).

Methods

From January 2008 to July 2010, 73 patients with sporadic unilateral RCC were enrolled to our study (57 men and 16 women, age range: 37–78 years, mean age 57.9 years). The diameter of the tumor was 1.7–5.8, 3.4 cm on average. The patients were divided into two groups depending on the intraoperative ultrasonography type: CEUS group and conventional ultrasound group. Patients in CEUS group received CEUS before insertion of the electrode, and the second CEUS was performed right after the initial ablation to dynamically evaluate the images. If there was highly suspicious residue, additional ablation and repeated CEUS were applied. Patients in the conventional ultrasound group received PRFA guided by gray-scale ultrasound. All of these patients received contrast-enhanced computed tomography (CT) examination 7 days after the procedure (patients in CEUS group received CEUS conducted with each CT scan), with subsequent CT and CEUS assessment at 3, 6, and every 6 months thereafter.

Results

The mean follow-up period was 22 months (range: 12–42 months). All tumors were biopsied before RFA. The local tumor control rate was 94.6% (35/37) in the CEUS group and 86.1% (31/36) in the conventional ultrasound group (P < 0.05); the cancer-specific survival rate and the overall survival rate were 100%. The post-RFA (12 months) mean GFR levels were 84.7 ± 27.5 mL/min/1.73 m2 (P > 0.05, compared with pre-GFR: 86.4 ± 26.2 mL/min/1.73 m2) in the CEUS group and 81.9 ± 22.8 mL/min/1.73 m2 (P > 0.05, compared with pre-GFR: 83.5 ± 23.7 mL/min/1.73 m2) in the conventional ultrasound group.

Conclusion

Intraoperative CEUS can “real-time” monitor the ablated area during PRFA procedure. This technique can help to achieve a higher success rate compared with conventional ultrasound. No impact of intraoperative CEUS has been found on GFR level.
Literatur
1.
Zurück zum Zitat Carraway WA, Raman JD, Cadeddu JA (2009) Current status of renal radiofrequency ablation. Curr Opin Urol 19:143–147CrossRefPubMed Carraway WA, Raman JD, Cadeddu JA (2009) Current status of renal radiofrequency ablation. Curr Opin Urol 19:143–147CrossRefPubMed
2.
Zurück zum Zitat Boss A, Clasen S, Kuczyk M, et al. (2007) Image-guided radiofrequency ablation of renal cell carcinoma. Eur Radiol 17:725–733CrossRefPubMed Boss A, Clasen S, Kuczyk M, et al. (2007) Image-guided radiofrequency ablation of renal cell carcinoma. Eur Radiol 17:725–733CrossRefPubMed
3.
Zurück zum Zitat Lyrdal D, Andersson M, Hellström M, et al. (2010) Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up. Acta Radiol 51:808–818CrossRefPubMed Lyrdal D, Andersson M, Hellström M, et al. (2010) Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up. Acta Radiol 51:808–818CrossRefPubMed
4.
Zurück zum Zitat Solbiati L, Goldberg SN, Ierace T, et al. (1999) Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent–early experience. Radiology 211:643–649CrossRefPubMed Solbiati L, Goldberg SN, Ierace T, et al. (1999) Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent–early experience. Radiology 211:643–649CrossRefPubMed
5.
Zurück zum Zitat Meloni MF, Bertolotto M, Alberzoni C, et al. (2008) Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI. AJR Am J Roentgenol 191:1233–1238CrossRefPubMed Meloni MF, Bertolotto M, Alberzoni C, et al. (2008) Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI. AJR Am J Roentgenol 191:1233–1238CrossRefPubMed
6.
Zurück zum Zitat Kong WT, Zhang WW, Guo HQ, et al. (2011) Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response? Abdom Imaging 36:342–347CrossRefPubMed Kong WT, Zhang WW, Guo HQ, et al. (2011) Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response? Abdom Imaging 36:342–347CrossRefPubMed
7.
Zurück zum Zitat Hoeffel C, Pousset M, Timsit MO, et al. (2010) Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour. Eur Radiol 20:1812–1821CrossRefPubMed Hoeffel C, Pousset M, Timsit MO, et al. (2010) Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour. Eur Radiol 20:1812–1821CrossRefPubMed
8.
Zurück zum Zitat Permpongkosol S, Link RE, Solomon SB, et al. (2006) Results of computerized tomography guided percutaneous ablation of renal masses with nondiagnostic pre-ablation pathological findings. J Urol 176:463–467CrossRefPubMed Permpongkosol S, Link RE, Solomon SB, et al. (2006) Results of computerized tomography guided percutaneous ablation of renal masses with nondiagnostic pre-ablation pathological findings. J Urol 176:463–467CrossRefPubMed
9.
Zurück zum Zitat Farrell MA, Charboneau WJ, DiMarco DS, et al. (2003) Imaging-guided radiofrequency ablation of solid renal tumours. AJR Am J Roentgenol 180:1509–1513CrossRefPubMed Farrell MA, Charboneau WJ, DiMarco DS, et al. (2003) Imaging-guided radiofrequency ablation of solid renal tumours. AJR Am J Roentgenol 180:1509–1513CrossRefPubMed
10.
Zurück zum Zitat Park S, Anderson JK, Matsumoto ED, et al. (2006) Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol 20:569–573CrossRefPubMed Park S, Anderson JK, Matsumoto ED, et al. (2006) Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol 20:569–573CrossRefPubMed
11.
Zurück zum Zitat Lucas SM, Stern JM, Adibi M, et al. (2008) Renal function outcomes inpatients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 179:75–79CrossRefPubMed Lucas SM, Stern JM, Adibi M, et al. (2008) Renal function outcomes inpatients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 179:75–79CrossRefPubMed
12.
Zurück zum Zitat Amersi FF, McElrath-Garza A, Ahmad A, et al. (2006) Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg 141:581–587CrossRefPubMed Amersi FF, McElrath-Garza A, Ahmad A, et al. (2006) Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg 141:581–587CrossRefPubMed
13.
Zurück zum Zitat Soong M, Jupiter J, Rosenthal D (2006) Radiofrequency ablation of osteoid osteoma in the upper extremity. J Hand Surg Am 31:279–283CrossRefPubMed Soong M, Jupiter J, Rosenthal D (2006) Radiofrequency ablation of osteoid osteoma in the upper extremity. J Hand Surg Am 31:279–283CrossRefPubMed
14.
Zurück zum Zitat Susini T, Nori J, Olivieri S, et al. (2007) Radiofrequency ablation for minimally invasive treatment of breast carcinoma. A pilot study in elderly inoperable patients. Gynecol Oncol 104:304–310CrossRefPubMed Susini T, Nori J, Olivieri S, et al. (2007) Radiofrequency ablation for minimally invasive treatment of breast carcinoma. A pilot study in elderly inoperable patients. Gynecol Oncol 104:304–310CrossRefPubMed
15.
Zurück zum Zitat Zagoria RJ, Pettus JA, Rogers M, et al. (2011) Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology 77:1393–1397CrossRefPubMed Zagoria RJ, Pettus JA, Rogers M, et al. (2011) Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology 77:1393–1397CrossRefPubMed
16.
Zurück zum Zitat Ferakis N, Bouropoulos C, Granitsas T, et al. (2010) Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors. J Endourol 24:1909–1913CrossRefPubMed Ferakis N, Bouropoulos C, Granitsas T, et al. (2010) Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors. J Endourol 24:1909–1913CrossRefPubMed
17.
Zurück zum Zitat Gervais DA, McGovern FJ, Arellano RS, et al. (2005) Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 185:64–71CrossRefPubMed Gervais DA, McGovern FJ, Arellano RS, et al. (2005) Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 185:64–71CrossRefPubMed
18.
Zurück zum Zitat Zagoria RJ, Traver MA, Werle DM, et al. (2007) Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 189:429–436CrossRefPubMed Zagoria RJ, Traver MA, Werle DM, et al. (2007) Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 189:429–436CrossRefPubMed
19.
Zurück zum Zitat Ji CW, Li XG, Zhang SW, et al. (2011) Laparoscopic radiofrequency ablation of renal tumors: 32-month mean follow-up results of 106 patients. Urology 77:798–802CrossRefPubMed Ji CW, Li XG, Zhang SW, et al. (2011) Laparoscopic radiofrequency ablation of renal tumors: 32-month mean follow-up results of 106 patients. Urology 77:798–802CrossRefPubMed
20.
Zurück zum Zitat Gupta A, Raman JD, Leveillee RJ, et al. (2009) General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results. J Endourol 23:1099–1105CrossRefPubMed Gupta A, Raman JD, Leveillee RJ, et al. (2009) General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results. J Endourol 23:1099–1105CrossRefPubMed
21.
Zurück zum Zitat Morcos SK, Thomsen HS, Webb JA (1999) Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9:1602–1613CrossRefPubMed Morcos SK, Thomsen HS, Webb JA (1999) Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9:1602–1613CrossRefPubMed
22.
Zurück zum Zitat Merkle EM, Nour SG, Lewin JS (2005) MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months. Radiology 235:1065–1071CrossRefPubMed Merkle EM, Nour SG, Lewin JS (2005) MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months. Radiology 235:1065–1071CrossRefPubMed
23.
Zurück zum Zitat Thomsen HS, Morcos SK, Barrett BJ (2008) Contrast-induced nephropathy: the wheel has turned 360 degrees. Acta Radiol 49:646–657CrossRefPubMed Thomsen HS, Morcos SK, Barrett BJ (2008) Contrast-induced nephropathy: the wheel has turned 360 degrees. Acta Radiol 49:646–657CrossRefPubMed
24.
Zurück zum Zitat Bartolotta TV, Taibbi A, Midiri M, et al. (2008) Hepatocellular cancer response to radiofrequency tumor ablation: contrast-enhanced ultrasound. Abdom Imaging 33:501–511CrossRefPubMed Bartolotta TV, Taibbi A, Midiri M, et al. (2008) Hepatocellular cancer response to radiofrequency tumor ablation: contrast-enhanced ultrasound. Abdom Imaging 33:501–511CrossRefPubMed
25.
Zurück zum Zitat Xu ZF, Xu HX, Xie XY, et al. (2010) Renal cell carcinoma: real-time contrast-enhanced ultrasound findings. Abdom Imaging 35:750–756CrossRefPubMed Xu ZF, Xu HX, Xie XY, et al. (2010) Renal cell carcinoma: real-time contrast-enhanced ultrasound findings. Abdom Imaging 35:750–756CrossRefPubMed
26.
Zurück zum Zitat Moschouris H, Stamatiou K, Kornezos I (2010) Re: Xu et al.: Renal cell carcinoma: real-time contrast-enhanced ultrasound finding. Abdom Imaging 35:507–509CrossRefPubMed Moschouris H, Stamatiou K, Kornezos I (2010) Re: Xu et al.: Renal cell carcinoma: real-time contrast-enhanced ultrasound finding. Abdom Imaging 35:507–509CrossRefPubMed
27.
Zurück zum Zitat Salvaggio G, Campisi A, Lo Greco V, et al. (2010) Evaluation of post treatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT. Abdom Imaging 35:447–453CrossRefPubMed Salvaggio G, Campisi A, Lo Greco V, et al. (2010) Evaluation of post treatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT. Abdom Imaging 35:447–453CrossRefPubMed
28.
Zurück zum Zitat Zhu Q, Shimizu T, Endo H, et al. (2005) Assessment of renal cell carcinoma after cryoablation using contrast-enhanced gray-scale ultrasound: a case series. Clin Imaging 29:102–108CrossRefPubMed Zhu Q, Shimizu T, Endo H, et al. (2005) Assessment of renal cell carcinoma after cryoablation using contrast-enhanced gray-scale ultrasound: a case series. Clin Imaging 29:102–108CrossRefPubMed
Metadaten
Titel
Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients
verfasst von
Xiaozhi Zhao
Wei Wang
Shiwei Zhang
Jun Liu
Fan Zhang
Changwei Ji
Xiaogong Li
Weidong Gan
Gutian Zhang
Hongqian Guo
Publikationsdatum
01.10.2012
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 5/2012
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-011-9828-4

Weitere Artikel der Ausgabe 5/2012

Abdominal Radiology 5/2012 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.